References: Empirical therapy for infective endocarditis
Allen CJ, Klein JL, Prendergast BD. Streptococcal Infective Endocarditis: "On the Origin of Species". Circulation 2020;142(8):731-3. https://www.ncbi.nlm.nih.gov/pubmed/32833516
Baddour LM, Wilson WR, Bayer AS, Fowler VG, Jr., Tleyjeh IM, Rybak MJ, et al. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation 2015;132(15):1435-86. https://www.ncbi.nlm.nih.gov/pubmed/26373316
Chamat-Hedemand S, Dahl A, Ostergaard L, Arpi M, Fosbol E, Boel J, et al. Prevalence of Infective Endocarditis in Streptococcal Bloodstream Infections Is Dependent on Streptococcal Species. Circulation 2020;142(8):720-30. https://www.ncbi.nlm.nih.gov/pubmed/32580572
Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015;36(44):3075-128. https://www.ncbi.nlm.nih.gov/pubmed/26320109
Ostergaard L, Voldstedlund M, Bruun NE, Bundgaard H, Iversen K, Kober N, et al. Temporal Changes, Patient Characteristics, and Mortality, According to Microbiological Cause of Infective Endocarditis: A Nationwide Study. J Am Heart Assoc 2022;11(16):e025801. https://www.ncbi.nlm.nih.gov/pubmed/35946455
Primus CP, Woldman S. Infective Endocarditis Remains a Deadly Disease-It's Bad News, Especially When Staphylococci and Enterococci Are Involved: A Call to Action. J Am Heart Assoc 2022;11(16):e026788. https://www.ncbi.nlm.nih.gov/pubmed/35946465
